IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-46321-9.html
   My bibliography  Save this article

Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria

Author

Listed:
  • Stian Foss

    (Oslo University Hospital
    University of Oslo
    University of Oslo)

  • Siri A. Sakya

    (Oslo University Hospital
    University of Oslo
    University of Oslo)

  • Leire Aguinagalde

    (University Medical Center Utrecht, Utrecht University)

  • Marta Lustig

    (Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein)

  • Jutamas Shaughnessy

    (University of Massachusetts Chan Medical School)

  • Ana Rita Cruz

    (University Medical Center Utrecht, Utrecht University)

  • Lisette Scheepmaker

    (University Medical Center Utrecht, Utrecht University)

  • Line Mathiesen

    (University of Copenhagen)

  • Fulgencio Ruso-Julve

    (Oslo University Hospital
    University of Oslo
    University of Oslo)

  • Aina Karen Anthi

    (Oslo University Hospital
    University of Oslo
    University of Oslo)

  • Torleif Tollefsrud Gjølberg

    (Oslo University Hospital
    University of Oslo
    University of Oslo)

  • Simone Mester

    (Oslo University Hospital
    University of Oslo
    University of Oslo)

  • Malin Bern

    (Oslo University Hospital
    University of Oslo
    University of Oslo)

  • Mitchell Evers

    (University Medical Center Utrecht)

  • Diane B. Bratlie

    (Norwegian Institute of Public Health)

  • Terje E. Michaelsen

    (Norwegian Institute of Public Health
    University of Oslo)

  • Tilman Schlothauer

    (Roche Innovation Center Munich)

  • Devin Sok

    (International AIDS Vaccine Initiative (IAVI))

  • Jayanta Bhattacharya

    (NCR Biotech Science Cluster)

  • Jeanette Leusen

    (University Medical Center Utrecht)

  • Thomas Valerius

    (Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein)

  • Sanjay Ram

    (University of Massachusetts Chan Medical School)

  • Suzan H. M. Rooijakkers

    (University Medical Center Utrecht, Utrecht University)

  • Inger Sandlie

    (University of Oslo)

  • Jan Terje Andersen

    (Oslo University Hospital
    University of Oslo
    University of Oslo)

Abstract

Monoclonal IgG antibodies constitute the fastest growing class of therapeutics. Thus, there is an intense interest to design more potent antibody formats, where long plasma half-life is a commercially competitive differentiator affecting dosing, frequency of administration and thereby potentially patient compliance. Here, we report on an Fc-engineered variant with three amino acid substitutions Q311R/M428E/N434W (REW), that enhances plasma half-life and mucosal distribution, as well as allows for needle-free delivery across respiratory epithelial barriers in human FcRn transgenic mice. In addition, the Fc-engineered variant improves on-target complement-mediated killing of cancer cells as well as both gram-positive and gram-negative bacteria. Hence, this versatile Fc technology should be broadly applicable in antibody design aiming for long-acting prophylactic or therapeutic interventions.

Suggested Citation

  • Stian Foss & Siri A. Sakya & Leire Aguinagalde & Marta Lustig & Jutamas Shaughnessy & Ana Rita Cruz & Lisette Scheepmaker & Line Mathiesen & Fulgencio Ruso-Julve & Aina Karen Anthi & Torleif Tollefsru, 2024. "Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-46321-9
    DOI: 10.1038/s41467-024-46321-9
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-46321-9
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-024-46321-9?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Chang-Han Lee & Tae Hyun Kang & Ophélie Godon & Makiko Watanabe & George Delidakis & Caitlin M. Gillis & Delphine Sterlin & David Hardy & Michel Cogné & Lynn E. Macdonald & Andrew J. Murphy & Naxin Tu, 2019. "An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence," Nature Communications, Nature, vol. 10(1), pages 1-11, December.
    2. Sung-Youl Ko & Amarendra Pegu & Rebecca S. Rudicell & Zhi-yong Yang & M. Gordon Joyce & Xuejun Chen & Keyun Wang & Saran Bao & Thomas D. Kraemer & Timo Rath & Ming Zeng & Stephen D. Schmidt & John-Pau, 2014. "Enhanced neonatal Fc receptor function improves protection against primate SHIV infection," Nature, Nature, vol. 514(7524), pages 642-645, October.
    3. Chang-Han Lee & Tae Hyun Kang & Ophélie Godon & Makiko Watanabe & George Delidakis & Caitlin M. Gillis & Delphine Sterlin & David Hardy & Michel Cogné & Lynn E. Macdonald & Andrew J. Murphy & Naxin Tu, 2019. "Publisher Correction: An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence," Nature Communications, Nature, vol. 10(1), pages 1-1, December.
    4. Algirdas Grevys & Jeannette Nilsen & Kine M. K. Sand & Muluneh B. Daba & Inger Øynebråten & Malin Bern & Martin B. McAdam & Stian Foss & Tilman Schlothauer & Terje E. Michaelsen & Gregory J. Christian, 2018. "A human endothelial cell-based recycling assay for screening of FcRn targeted molecules," Nature Communications, Nature, vol. 9(1), pages 1-14, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Sasha B. Ebrahimi & Devleena Samanta, 2023. "Engineering protein-based therapeutics through structural and chemical design," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    2. Karunasinee Suphaphiphat & Delphine Desjardins & Valérie Lorin & Nastasia Dimant & Kawthar Bouchemal & Laetitia Bossevot & Maxence Galpin-Lebreau & Nathalie Dereuddre-Bosquet & Hugo Mouquet & Roger Gr, 2023. "Mucosal application of the broadly neutralizing antibody 10-1074 protects macaques from cell-associated SHIV vaginal exposure," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    3. Lucia Reh & Carsten Magnus & Merle Schanz & Jacqueline Weber & Therese Uhr & Peter Rusert & Alexandra Trkola, 2015. "Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent," PLOS Pathogens, Public Library of Science, vol. 11(7), pages 1-34, July.
    4. Fangzhu Zhao & Zachary T. Berndsen & Nuria Pedreño-Lopez & Alison Burns & Joel D. Allen & Shawn Barman & Wen-Hsin Lee & Srirupa Chakraborty & Sandrasegaram Gnanakaran & Leigh M. Sewall & Gabriel Ozoro, 2022. "Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    5. Torleif Tollefsrud Gjølberg & Jonas Aakre Wik & Hanna Johannessen & Stig Krüger & Nicola Bassi & Panagiotis F. Christopoulos & Malin Bern & Stian Foss & Goran Petrovski & Morten C. Moe & Guttorm Haral, 2023. "Antibody blockade of Jagged1 attenuates choroidal neovascularization," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    6. Yunda Huang & Lily Zhang & Shelly Karuna & Philip Andrew & Michal Juraska & Joshua A. Weiner & Heather Angier & Evgenii Morgan & Yasmin Azzam & Edith Swann & Srilatha Edupuganti & Nyaradzo M. Mgodi & , 2023. "Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    7. Maximilian Brinkhaus & Erwin Pannecoucke & Elvera J. Kooi & Arthur E. H. Bentlage & Ninotska I. L. Derksen & Julie Andries & Bianca Balbino & Magdalena Sips & Peter Ulrichts & Peter Verheesen & Hans H, 2022. "The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement," Nature Communications, Nature, vol. 13(1), pages 1-14, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-46321-9. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.